Sanofi - Asset Resilience Ratio

Latest as of December 2025: 0.64%

Sanofi (SNYN) has an Asset Resilience Ratio of 0.64% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

MX$810.00 Million

≈ $46.62 Million USD Cash + Short-term Investments

Total Assets

MX$126.81 Billion

≈ $7.30 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Sanofi's Asset Resilience Ratio has changed over time. Check Sanofi strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Sanofi's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sanofi market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	MX$0.00	0%
Short-term Investments	MX$810.00 Million	0.64%
Total Liquid Assets	MX$810.00 Million	0.64%

Asset Resilience Insights

Limited Liquidity: Sanofi maintains only 0.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sanofi Industry Peers by Asset Resilience Ratio

Compare Sanofi's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
Virbac SA PA:VIRP	Drug Manufacturers - General	0.23%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
NanJing Pharmaceutical Co Ltd SHG:600713	Drug Manufacturers - General	0.85%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	7.83%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%

Annual Asset Resilience Ratio for Sanofi (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Sanofi.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.64%	MX$810.00 Million ≈ $46.62 Million	MX$126.81 Billion ≈ $7.30 Billion	+0.27pp
2024-12-31	0.37%	MX$486.00 Million ≈ $27.97 Million	MX$132.80 Billion ≈ $7.64 Billion	+0.15pp
2023-12-31	0.21%	MX$270.00 Million ≈ $15.54 Million	MX$126.46 Billion ≈ $7.28 Billion	-0.32pp
2022-12-31	0.53%	MX$664.00 Million ≈ $38.21 Million	MX$124.58 Billion ≈ $7.17 Billion	-0.34pp
2021-12-31	0.88%	MX$1.05 Billion ≈ $60.66 Million	MX$120.24 Billion ≈ $6.92 Billion	+0.09pp
2020-12-31	0.79%	MX$900.00 Million ≈ $51.80 Million	MX$114.53 Billion ≈ $6.59 Billion	+0.41pp
2019-12-31	0.38%	MX$426.00 Million ≈ $24.52 Million	MX$112.74 Billion ≈ $6.49 Billion	+0.20pp
2018-12-31	0.18%	MX$199.00 Million ≈ $11.45 Million	MX$111.41 Billion ≈ $6.41 Billion	+0.10pp
2017-12-31	0.08%	MX$77.00 Million ≈ $4.43 Million	MX$99.83 Billion ≈ $5.75 Billion	+0.05pp
2016-12-31	0.03%	MX$31.00 Million ≈ $1.78 Million	MX$104.67 Billion ≈ $6.02 Billion	+0.02pp
2015-12-31	0.01%	MX$13.00 Million ≈ $748.15K	MX$102.32 Billion ≈ $5.89 Billion	+0.00pp
2014-12-31	0.01%	MX$9.00 Million ≈ $517.95K	MX$97.39 Billion ≈ $5.60 Billion	-0.05pp
2013-12-31	0.06%	MX$59.00 Million ≈ $3.40 Million	MX$96.06 Billion ≈ $5.53 Billion	--

pp = percentage points

About Sanofi

MX:SNYN Mexico Drug Manufacturers - General

Market Cap

$102.08 Billion

MX$1.77 Trillion MXN

Market Cap Rank

#247 Global

#9 in Mexico

Share Price

MX$741.00

Change (1 day)

+0.00%

52-Week Range

MX$730.00 - MX$955.00

All Time High

MX$1212.00